. 2015 Sep 22;25(6):989–995. doi: 10.1111/jon.12293
© 2015 The Authors. Journal of Neuroimaging published by Wiley Periodicals, Inc. on behalf of American Society of Neuroimaging
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Figure 1.
Study design. GA40 = glatiramer acetate 40 mg/mL three times weekly.